A mixed method analysis of toxicities of anti-CD19-CAR T cell therapy in hematological malignancies.

Vishal Jindal,Padmastuti Akella,Paramarajan Piranavan,Ahmad Daniyal Siddiqui

A mixed method analysis of toxicities of anti-CD19-CAR T cell therapy in hematological malignancies.

2019

Vishal Jindal
Padmastuti Akella
Paramarajan Piranavan
Ahmad Daniyal Siddiqui

e19068Background: CAR (Chimeric Antigen Receptor) T cell therapy is a promising therapy with significant benefits. But cytokine release syndrome (CRS) and neurological toxicities (NT) are major obs...

Keywords:

Cancer research
Pathology
Cytokine release syndrome
CAR T-cell therapy
Chimeric antigen receptor
CD19
Medicine
T cell
anti cd19

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations